Particularly, for hormone receptor-positive, early breast cancer it needs to be emphasized that not a single biomarker, but the pattern of the four biomarkers and clinicopathological parameters including stage (reflecting tumor size and nodal status) and histopathological grade is informative for clinical decisions.12 The gene discussed is NR4A1; the disease is neoplasm.